| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-03 20:58:34 UTC |
|---|
| Updated at | 2022-09-03 20:58:34 UTC |
|---|
| NP-MRD ID | NP0182319 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (11r)-2-methyl-11-(morpholin-4-ylmethyl)-3-(naphthalene-1-carbonyl)-9-oxa-1-azatricyclo[6.3.1.0⁴,¹²]dodeca-2,4,6,8(12)-tetraene |
|---|
| Description | WIN 55212-2, also known as win 55,212 or (R)-win-55212, belongs to the class of organic compounds known as naphthoylindoles. These are polycyclic compounds containing an indole moiety that is N-linked to the carboxamide group attached to naphthalene. (11r)-2-methyl-11-(morpholin-4-ylmethyl)-3-(naphthalene-1-carbonyl)-9-oxa-1-azatricyclo[6.3.1.0⁴,¹²]dodeca-2,4,6,8(12)-tetraene was first documented in 2003 (PMID: 14512703). Based on a literature review a significant number of articles have been published on WIN 55212-2 (PMID: 35674874) (PMID: 33371336) (PMID: 32710782) (PMID: 31181184) (PMID: 29883990) (PMID: 29627825). |
|---|
| Structure | CC1=C(C(=O)C2=C3C=CC=CC3=CC=C2)C2=CC=CC3=C2N1[C@H](CN1CCOCC1)CO3 InChI=1S/C27H26N2O3/c1-18-25(27(30)22-9-4-7-19-6-2-3-8-21(19)22)23-10-5-11-24-26(23)29(18)20(17-32-24)16-28-12-14-31-15-13-28/h2-11,20H,12-17H2,1H3/t20-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone | ChEBI | | Win 55,212 | ChEBI | | (2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonate | MeSH | | (3R)-((2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone monomethanesulfonate | MeSH | | (3R)-((2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone | MeSH | | ((3R)-2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone, methanesulfonate (1:1) | MeSH | | (+)-((2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone monomethanesulfonate | MeSH | | (R)-(+)-WIN-55212-2 | MeSH | | (R)-WIN-55212 | MeSH | | WIN 55212-2 mesylate | MeSH | | (3S)-((2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone | MeSH | | (R)-(+)-WIN 55212-2 mesylate | MeSH | | 2,3-Dihydro-5-methyl-3((4-morpholinyl)methyl) pyrrolo(1,2,3,-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl methanone | MeSH |
|
|---|
| Chemical Formula | C27H26N2O3 |
|---|
| Average Mass | 426.5160 Da |
|---|
| Monoisotopic Mass | 426.19434 Da |
|---|
| IUPAC Name | (11R)-2-methyl-11-[(morpholin-4-yl)methyl]-3-(naphthalene-1-carbonyl)-9-oxa-1-azatricyclo[6.3.1.0^{4,12}]dodeca-2,4,6,8(12)-tetraene |
|---|
| Traditional Name | (11R)-2-methyl-11-(morpholin-4-ylmethyl)-3-(naphthalene-1-carbonyl)-9-oxa-1-azatricyclo[6.3.1.0^{4,12}]dodeca-2,4,6,8(12)-tetraene |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=C(C(=O)C2=C3C=CC=CC3=CC=C2)C2=CC=CC3=C2N1[C@H](CN1CCOCC1)CO3 |
|---|
| InChI Identifier | InChI=1S/C27H26N2O3/c1-18-25(27(30)22-9-4-7-19-6-2-3-8-21(19)22)23-10-5-11-24-26(23)29(18)20(17-32-24)16-28-12-14-31-15-13-28/h2-11,20H,12-17H2,1H3/t20-/m1/s1 |
|---|
| InChI Key | HQVHOQAKMCMIIM-HXUWFJFHSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as naphthoylindoles. These are polycyclic compounds containing an indole moiety that is N-linked to the carboxamide group attached to naphthalene. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Naphthoylindoles |
|---|
| Direct Parent | Naphthoylindoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Naphthoylindole
- Benzoylindole
- 1-naphthalenecarboxylic acid or derivatives
- Indolecarboxylic acid derivative
- Benzoxazine
- Naphthalene
- Indole
- Aryl ketone
- Alkyl aryl ether
- Morpholine
- Oxazinane
- Substituted pyrrole
- Benzenoid
- Vinylogous amide
- Pyrrole
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Ketone
- Dialkyl ether
- Ether
- Azacycle
- Oxacycle
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Organopnictogen compound
- Organonitrogen compound
- Organic nitrogen compound
- Amine
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - He Q, Zhang W, Zhang J, Deng Y: Cannabinoid Analogue WIN 55212-2 Protects Paraquat-Induced Lung Injury and Enhances Macrophage M2 Polarization. Inflammation. 2022 Dec;45(6):2256-2267. doi: 10.1007/s10753-022-01688-z. Epub 2022 Jun 8. [PubMed:35674874 ]
- Liu QR, Canseco-Alba A, Liang Y, Ishiguro H, Onaivi ES: Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects. Int J Mol Sci. 2020 Dec 21;21(24):9763. doi: 10.3390/ijms21249763. [PubMed:33371336 ]
- Perez-Valenzuela EJ, Andres Coke ME, Grace AA, Fuentealba Evans JA: Adolescent Exposure to WIN 55212-2 Render the Nigrostriatal Dopaminergic Pathway Activated During Adulthood. Int J Neuropsychopharmacol. 2020 Dec 3;23(9):626-637. doi: 10.1093/ijnp/pyaa053. [PubMed:32710782 ]
- Perez-Valenzuela E, Castillo-Faundez R, Fuentealba JA: Comparing dopaminergic dynamics in the dorsolateral striatum between adolescent and adult rats: Effect of an acute dose of WIN55212-2. Brain Res. 2019 Sep 15;1719:235-242. doi: 10.1016/j.brainres.2019.06.005. Epub 2019 Jun 7. [PubMed:31181184 ]
- Gholizadeh F, Ghahremani MH, Aliebrahimi S, Shadboorestan A, Ostad SN: Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells. Iran Biomed J. 2019 Mar;23(2):153-8. doi: 10.29252/.23.2.153. Epub 2018 Jun 9. [PubMed:29883990 ]
- Donnerer J, Liebmann I: Effect of CB1 Ligands on Neurogenic and Myogenic Contractile Responses in the Guinea-Pig Ileum. Pharmacology. 2018;101(5-6):330-336. doi: 10.1159/000488682. Epub 2018 Apr 6. [PubMed:29627825 ]
- Neves LMS, Goncalves ECD, Cavalli J, Vieira G, Laurindo LR, Simoes RR, Coelho IS, Santos ARS, Marcolino AM, Cola M, Dutra RC: Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K(+) Channel/p38-MAPK Signalling Pathway. Mol Neurobiol. 2018 Jul;55(7):5580-5593. doi: 10.1007/s12035-017-0792-z. Epub 2017 Oct 4. [PubMed:28980210 ]
- Aguilar MA, Ledesma JC, Rodriguez-Arias M, Penalva C, Manzanedo C, Minarro J, Arenas MC: Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice. Int J Mol Sci. 2017 Jun 21;18(6):1326. doi: 10.3390/ijms18061326. [PubMed:28635664 ]
- Araujo DSM, Miya-Coreixas VS, Pandolfo P, Calaza KC: Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia. Exp Eye Res. 2017 Jan;154:116-125. doi: 10.1016/j.exer.2016.11.015. Epub 2016 Nov 19. [PubMed:27876485 ]
- Rodriguez-Arias M, Roger-Sanchez C, Villanova I, Revert N, Manzanedo C, Minarro J, Aguilar MA: Corrigendum to "Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait". Neural Plast. 2016;2016:6702083. doi: 10.1155/2016/6702083. Epub 2016 Jul 28. [PubMed:27547455 ]
- Costain WJ, Tauskela JS, Rasquinha I, Comas T, Hewitt M, Marleau V, Soo EC: Pharmacological characterization of emerging synthetic cannabinoids in HEK293T cells and hippocampal neurons. Eur J Pharmacol. 2016 Sep 5;786:234-245. doi: 10.1016/j.ejphar.2016.05.040. Epub 2016 May 31. [PubMed:27260125 ]
- Rodriguez-Arias M, Roger-Sanchez C, Vilanova I, Revert N, Manzanedo C, Minarro J, Aguilar MA: Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait. Neural Plast. 2016;2016:6481862. doi: 10.1155/2016/6481862. Epub 2015 Dec 31. [PubMed:26881125 ]
- Chiodi V, Ferrante A, Ferraro L, Potenza RL, Armida M, Beggiato S, Pezzola A, Bader M, Fuxe K, Popoli P, Domenici MR: Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors. J Neurochem. 2016 Mar;136(5):907-17. doi: 10.1111/jnc.13421. Epub 2015 Nov 24. [PubMed:26526685 ]
- Toguri JT, Moxsom R, Szczesniak AM, Zhou J, Kelly ME, Lehmann C: Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation. Clin Hemorheol Microcirc. 2015;61(2):237-49. doi: 10.3233/CH-151996. [PubMed:26410875 ]
- Soni N, Kohlmeier KA: Endocannabinoid CB1 receptor-mediated rises in Ca(2+) and depolarization-induced suppression of inhibition within the laterodorsal tegmental nucleus. Brain Struct Funct. 2016 Apr;221(3):1255-77. doi: 10.1007/s00429-014-0969-4. Epub 2015 Jan 9. [PubMed:25573246 ]
- Pozzi O, Misiano P, Clark GD, Visentin L: Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A. Pharmacology. 2003 Nov;69(3):158-63. doi: 10.1159/000072669. [PubMed:14512703 ]
- Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O: The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues. J Pharmacol Sci. 2005 May;98(1):77-82. doi: 10.1254/jphs.fp0050171. Epub 2005 May 12. [PubMed:15888960 ]
- Rawls SM, Gomez T, Raffa RB: An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol Biochem Behav. 2007 Mar;86(3):499-504. doi: 10.1016/j.pbb.2007.01.010. Epub 2007 Jan 20. [PubMed:17306870 ]
- Rodriguez-Arias M, Manzanedo C, Roger-Sanchez C, Do Couto BR, Aguilar MA, Minarro J: Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):166-71. doi: 10.1016/j.pnpbp.2009.10.019. Epub 2009 Oct 30. [PubMed:19883712 ]
- Yuce B, Kemmer M, Qian G, Muller M, Sibaev A, Li Y, Kreis ME, Storr M: Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat. Neurogastroenterol Motil. 2010 Jun;22(6):672-e205. doi: 10.1111/j.1365-2982.2010.01473.x. Epub 2010 Feb 18. [PubMed:20158615 ]
- LOTUS database [Link]
|
|---|